Antiproliferative and differentiating effects of benzodiazepine receptor ligands on B16 melanoma cells

Biochemical Pharmacology

Volumn 56, Issue 8, 1998, Pages 1029-1034

  Landau, Marina ^a,b   Weizman, Abraham ^a   Zoref Shani, Esther ^a,c   Beery, Einat ^a   Wasseman, Lina ^a   Landau, Ofer ^a   Gavish, Moshe ^d   Brenner, Sarah ^a,b   Nordenberg, Jardena ^a,d  

^a TEL AVIV UNIVERSITY   (Israel)

^b Department of Dermatology   (Israel)

^c Tel Aviv University ^*  (Israel)

^d TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

glutamyl transpeptidase; Benzodiazepine receptor; Cell cycle; Cell proliferation; Melanoma

Indexed keywords

4' CHLORODIAZEPAM; BENZODIAZEPINE RECEPTOR; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; CLONAZEPAM; DIAZEPAM; GAMMA GLUTAMYLTRANSFERASE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG EFFECT; MELANOGENESIS; MELANOMA B16; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; BENZODIAZEPINONES; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CLONAZEPAM; DIAZEPAM; GABA AGENTS; GAMMA-GLUTAMYLTRANSFERASE; ISOQUINOLINES; MELANOMA, EXPERIMENTAL; MICE; NUCLEOTIDES; PHENOTYPE; TUMOR CELLS, CULTURED;

EID: 0032531940     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00149-X     Document Type: Article

References (32)

1. Costa E., Guidotti A. Diazepam binding inhibitor (DBI): a peptide with multiple biologic activities. Life Sci. 49:1991;325-344.
2. Moingeon P., Bidart J.M., Allberici G.F., Bohuon C. Characterization of the peripheral type benzodiazepine binding site on human circulating lymphocytes. Eur J Pharmacol. 92:1983;147-149.
3. Wang J.K., Morgan J.I., Spector S. Benzodiazepines that bind at peripheral sites inhibit cell proliferation. Proc Natl Acad Sci. USA. 81:1984;753-756.
4. Pawlikowski M., Kunert-Radek J., Stepien H., Radek A. Diazepam inhibits proliferation of the mouse spleen lymphocytes in vitro. Pol J Pharmacol Pharm. 38:1986;167-170.
5. Matthew E., Laskin J.D., Zimmerman E.A., Weinstein I.B., Hsu K.D., Englehardt D.L. Benzodiazepines have high-affinity binding sites and induce melanogenesis in B16/C3 melanoma cells. Proc Natl Acad Sci USA. 78:1981;3935-3939.
6. Gorman A.M., O'Beirne G.B., Regan C.M., Williams D.C. Antiproliferative action of benzodiazepines in cultured brain cells is not mediated through the peripheral type benzodiazepine acceptors. J Neurochem. 53:1989;849-855.
7. Stepien H., Pawlikowski A., Pawlikowski M. Effects of benzodiazepines on thymus cell proliferation. Thymus. 12:1988;117-121.
8. Ikezaki K., Black K.L. Stimulation of cell growth and DNA synthesis by peripheral benzodiazepines. Cancer Lett. 49:1990;115-120.
9. Clarke G.D., Ryan P.J. Tranquilizers can block mitogenesis in 3T3 cells and induce differentiation in Friend cells. Nature. 287:1980;160-161.
10. Curran T., Morgan J.I. Superinduction of c-fos by nerve growth factor in the presence of active benzodiazepines. Science. 229:1985;1265-1268.
11. Nordenberg J., Kornfeld J., Wasserman L., Shafran M., Halabe E., Beery E., Landau O., Novogrodsky A., Sidi Y. Novobiocin modulates colchicine sensitivity in parental and multidrug-resistant B16 melanoma cells. J Cancer Res Clin Oncol. 120:1994;599-604.
12. Venderløv L.L., Christensen I.J., Nissen N.I. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry. 3:1983;323-327.
13. Wasserman L., Kessler I., Cehsu G. A simple method for the preparation of permanent slides from cell cultures. Stain Technol. 59:1984;353-354.
14. Pearse AGE, Histochemistry: Theoretical and Applied (3rd edition), vol. 1. p. 697. Churchill, London, 1968.
15. Tate S.S., Meister A. Interaction of γ glutamyl transpeptidase with amino acids, dipeptides and derivatives and analogs of glutathione. J Biol Chem. 249:1974;7593-7602.
16. Labarca C., Paigen K. A simple rapid and sensitive DNA assay procedure. Anal Biochem. 102:1980;344-352.
17. Sidi Y., Hudson J.L., Mitchell B.S. Effects of guanine ribonucleotide accumulation on metabolism and cell cycle of human lymphoid cells. Cancer Res. 45:1985;4940-4945.
18. Nordenberg J., Wasserman L., Peled A., Malik Z., Stenzel K.H., Novogrodsky A. Biochemical and ultrastructural alterations accompanying the anti-proliferative effect of butyrate on melanoma cells. Br J Cancer. 55:1987;493-497.
19. Takahashi H., Parsons P.G. In vitro phenotypic alteration of human melanoma cells induced by differentiating agents: Heterogenous effects on cellular growth and morphology, enzymatic activity and antigenic expression. Pigment Cell Res. 3:1990;223-232.
20. Hirsch J.D., Beyer C.F., Malkowitz L., Beer B., Blume A.J. Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control. Mol Pharmacol. 35:1989;157-163.
21. Solowey W.E., Pestka S., Spector S., Fryer R.I., Fisher P.B. Peripheral acting benzodiazepines inhibit the growth of human melanoma cells and potentiate the antiproliferative activity of recombinant human interferons. J Interferon Res. 10:1990;269-280.
22. Hornback N.B., Shen R.N., Sutton G.P., Shidnia H., Kaiser H.E. Synergistic cytotoxic and antitumor effect of irradiation and taxol on human HeLa cervix carcinoma and mouse B16 melanoma cells. In Vivo. 8:1994;819-823.
23. Dulrez L., Goldwasser F., Genne P., Pommier Y., Solary E. The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase 49 and 2 inhibitors. Leukemia. 9:1995;1013-1024.
24. Petru E., Sevin B.V., Hoas J., Ramos R., Pevias J. A correlation of cell cycle perturbation with chemosensitivity in human ovarian cancer cells exposed to cytotoxic drugs in vitro. Gynecol Oncol. 5:1995;48-57.
25. Wintersberger E., Mudrak I., Wintersberger U. Butyrate inhibits mouse fibroblasts in a control point in the G1 phase. J Cell Biochem. 21:1983;239-247.
26. Nordenberg J., Wasserman L., Beery E., Aloni D., Malik H., Stenzel K.H., Novogrodsky A. Growth inhibition of murine melanoma by butyric acid and DMSO. Exp Cell Res. 162:1986;77-85.
27. Nordenberg J., Wasserman L., Gutman H., Beery E., Novogrodsky A. Growth inhibition and induction of phenotypic alterations by L-histidinol in B16 melanoma cells. Cancer Lett. 47:1989;193-197.
28. Fux A., Novogrodsky A., Sidi Y., Kessler-Icekson G., Wasserman L., Nordenberg J. Dimethylthiourea inhibition of B16 melanoma growth and induction of phenotypic alterations: Relationship to ATP levels. Br J Cancer. 63:1991;489-494.
29. Nordenberg J., Novogrodsky A., Beery E., Patia M., Wasserman L., Warshawsky A. Anti-proliferative effect and phenotypic alterations induced by 8-hydroxyquinoline in melanoma cell lines. Eur J Cancer. 26:1990;905-907.
30. Weber G., Lui M.S., Natsumeda Y., Faderan M.A. Salvage capacity of hepatoma 3924 A and action of dipyridamole. Adv Enzyme Regul. 21:1983;53-69.
31. Zoref-Shani E., Lavie R., Bromberg Y., Beery E., Sidi Y., Sperling O., Nordenberg J. Effects of differentiation inducing agents on purine nucleotide ovarian cancer cell line. J Cancer Res Clin Oncol. 120:1994;717-722.
32. Sidi Y., Beery E., Panet C., Wasserman L., Novogrodsky A., Nordenberg J. Growth inhibition and induction of phenotypic alteration by tiazofurin: Differential effects on MCF-7 breast cancer and HBL-100 breast cell lines. Eur J Cancer Clin Oncol. 25:1989;883-889.